Page 197 - Binder2

Because in a world where most biologics fail due to
immune rejection, designing for digestion isn't just an
engineering challenge.

It's a tolerogenic opportunity.

4. The Next Generation of Biologic Architecture

Plant-based systems began as a workaround—an alternative
platform for producing biologic drugs when conventional
manufacturing proved too costly, too slow, or too fragile.
But they’ve evolved into something much more ambitious.

With advances in genetic engineering, immune modeling,
and plant molecular biology, edible biologics are no
longer catching up to traditional platforms—they’re
starting to surpass them in critical dimensions:

195